Moderna's upcoming RSV shot utilizes mRNA technology to expand treatment capabilities, moving beyond Covid to address a range of illnesses like the flu and cancer.
Despite uncertainties about the RSV shot's efficacy compared to existing options, Moderna's CEO remains confident in the mRNA platform's potential to revolutionize healthcare globally.
[
add
]
[
|
|
...
]